Advertisement
Advertisement
U.S. markets open in 1 hour 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NexgenRx Inc. (NEGXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.27470.0000 (0.00%)
At close: 10:31AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2747
Open0.2747
BidN/A x N/A
AskN/A x N/A
Day's Range0.2747 - 0.2747
52 Week Range0.2560 - 0.3700
Volume800
Avg. Volume12
Market Cap20.531M
Beta (5Y Monthly)0.05
PE Ratio (TTM)6.87
EPS (TTM)0.0400
Earnings DateN/A
Forward Dividend & Yield0.02 (5.74%)
Ex-Dividend DateJan 27, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NEGXF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NEXGENRX INC
    Analyst Report: Swiss Re AGSwiss Re was established in 1863 in Zurich. Since then the business appears to have cycled through quite a few strategies. Namely in the early part of the millennium Swiss Re took on an investment banker who eventually led the business. Over the next 10 years CEO Jacques Aigrain built Swiss Re's financial solutions into a powerhouse and helped the company complete its first securitisation, finalised in 2005 for credit reinsurance. This division became a leader for Swiss Re but then disaster struck during the global financial crisis. Swiss Re mothballed this unit and approved a CHF 5 billion capital raise. Now the business concentrates more fundamentally on property and casualty, life and health reinsurance. Swiss Re also has a good commercial insurance offering named corporate solutions.
    Rating
    Fair Value
    Economic Moat
    21 days agoMorningstar
View more
Advertisement
Advertisement